ZebraMed Information

ZebraMed is a Paris-based TechBio company automating the ethical generation of living organisms’ data via a proprietary robotics platform, zebrafish embryo models, and human data to generate digital Systemic Human Profiles to enable predictive AI-driven drug discovery. The pharmaceutical industry pours billions into AI, yet 90% of therapeutic candidates fail because current models are built on flat, single-target in vitro data. Cells simply cannot capture human systemic complexity. ZebraMed aims to discover new therapies for untreatable systemic profiles, taking into account human complexity and variability. ZebraMed is the only solution extracting data closest to humans, and we are the first to train a transparent AI architecture that predicts targets and explains the biology and decision-making process. By addressing the lack of insight into human systemic response with highly translatable, large-scale data, ZebraMed discovers new therapeutic assets and empowers pharmaceutical partners to reduce preclinical timelines by 50% and increase success and rescue rates in pharmaceutical pipelines. Visit zebramed.bio.